Naming Treatment for Aphasia
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the Criterion-learning Based Naming Treatment for aphasia?
Research shows that semantic-based treatments, which focus on understanding the meaning of words, are generally more effective for improving naming abilities in people with aphasia compared to phonological treatments, which focus on the sounds of words. This suggests that treatments like Criterion-learning Based Naming Treatment, which may include semantic elements, could be beneficial for naming difficulties in aphasia.12345
Is the Naming Treatment for Aphasia safe for humans?
How does Criterion-learning Based Naming Treatment for aphasia differ from other treatments?
Criterion-learning Based Naming Treatment is unique because it focuses on specific learning mechanisms to improve naming abilities in aphasia, potentially incorporating elements like errorless learning, errorful learning, and retrieval practice to maximize treatment gains. This approach is distinct from other treatments that may focus solely on semantic or phonological cues.23489
What is the purpose of this trial?
Aphasia is a disorder of spoken and written language, most commonly following a stroke. It is estimated that between 2.5 and 4 million Americans are living with aphasia today. A common problem in aphasia involves difficulty retrieving known words in the course of language production and comprehension. The overarching goal of this project is to develop and test early efficacy, efficiency, and the tolerability of a lexical treatment for aphasia in multiple-session regimens that are comprised of retrieval practice, distributed practice, and training dedicated to the elicitation of correct retrievals. The aim of this work is to add to and refine the evidence base for the implementation and optimization of these elements in the treatment of production and comprehension deficits in aphasia, and make important steps towards an ultimate goal of self-administered lexical treatment grounded in retrieval practice principles (RPP) to supplement traditional speech-language therapy that is appropriate for People with Aphasia (PWA) from a broad level of severity of lexical processing deficit in naming and/or comprehension. This project cumulatively builds on prior work to develop a theory of learning for lexical processing impairment in aphasia that aims to ultimately explain why and for whom familiar lexical treatments work, and how to maximize the benefits they confer.
Research Team
Erica L Middleton, PhD
Principal Investigator
Albert Einstein Healthcare Network
Eligibility Criteria
This trial is for adults who have had a stroke at least 6 months ago and primarily speak English. It's designed to help those with aphasia, which is a language disorder affecting speech and comprehension.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a multi-session naming treatment study with criterion-learning practice, involving five training sessions generally separated by one week.
Retention Test
A retention test of naming performance is administered approximately one week following the final training session to assess naming mastery.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with additional retention tests approximately one week and one month post-treatment.
Treatment Details
Interventions
- Criterion-learning Based Naming Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Albert Einstein Healthcare Network
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Thomas Jefferson University
Collaborator